Nutex Health, Inc.NUTXNASDAQ
Loading
EBITDA Margin Over TimeStrong
Percentile Rank73
5Y CAGR-11.2%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

5Y CAGR
-11.2%/yr
Long-term compound
Percentile
P73
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
3 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM31.89%+3.0%
202430.97%+626.0%
2023-5.89%+96.7%
2022-179.68%-424.7%
202155.33%-4.1%
202057.68%+47.0%
201939.25%+104.3%
2018-919.10%+90.3%
2017-9516.09%-28616.4%
2011-33.14%-